Researchers from The University of Queensland & Mater Research will present their findings alongside Microba’s Dr David Wood in a webinar on ex...
We are innovating to help humanity achieve some of its most inspiring medical advancements in the 21st century. Read about Microba’s progress, partnership news and latest discoveries.
Microba Life Sciences, a precision microbiome science company, will showcase its Therapeutic Platform and Discovery Platform for the identific...
Microba receives ISO15189 accreditation for untargeted metagenomic assay of stool samples, unlocking diagnostic applications of the microbiome.
Leading Australian universities will explore the ‘cognobiome’ of soldiers using Microba’s analysis platform to discover opportunities for improving...
Results published in Cell show dietary restriction drives microbiome diversity changes in autistic individuals.
Microba will work with Anatara to complete microbiome analysis for a much-needed therapeutic treatment for sufferers of IBS-D.
Using the NEW1000 Family Study, researchers will investigate the role of the microbiome in the developmental origins of health and disease.
A/Prof Lutz Krause and Dr David Wood discuss practical applications of metagenomics in microbiome discovery at ASM's Annual Scientific Meeting.
Microba Life Sciences has united with Illumina, Inc. to advance understanding of the human gut microbiome in human health and disease.